126 related articles for article (PubMed ID: 36002847)
1. Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.
Pozzar RA; Xiong N; Hong F; Filson CP; Chang P; Halpenny B; Berry DL
BMC Med Inform Decis Mak; 2022 Aug; 22(1):223. PubMed ID: 36002847
[TBL] [Abstract][Full Text] [Related]
2. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
Bosco JL; Halpenny B; Berry DL
Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
[TBL] [Abstract][Full Text] [Related]
3. Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer.
Smith AB; Mancuso P; Sidhom M; Wong K; Berry M; Rincones O; Forstner D; Bokey L; Girgis A
BMJ Open; 2017 Nov; 7(11):e018403. PubMed ID: 29102996
[TBL] [Abstract][Full Text] [Related]
4. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
[TBL] [Abstract][Full Text] [Related]
5. Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer.
Smith A'; Rincones O; Mancuso P; Sidhom M; Wong K; Berry M; Forstner D; Ngo D; Bokey L; Girgis A
Urol Oncol; 2022 Jan; 40(1):8.e1-8.e9. PubMed ID: 34116935
[TBL] [Abstract][Full Text] [Related]
6. Patient Preferences and Treatment Decisions for Prostate Cancer: Results From A Statewide Urological Quality Improvement Collaborative.
Paudel R; Ferrante S; Qi J; Dunn RL; Berry DL; Semerjian A; Brede CM; George AK; Lane BR; Ginsburg KB; Montie JE; Lane GI;
Urology; 2021 Sep; 155():55-61. PubMed ID: 33933504
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer.
Berry DL; Halpenny B; Wolpin S; Davison BJ; Ellis WJ; Lober WB; McReynolds J; Wulff J
J Med Internet Res; 2010 Dec; 12(4):e67. PubMed ID: 21169159
[TBL] [Abstract][Full Text] [Related]
8. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M
Urol Oncol; 2021 Aug; 39(8):493.e9-493.e15. PubMed ID: 33353864
[TBL] [Abstract][Full Text] [Related]
9. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.
Perlis N; Sayyid R; Evans A; Van Der Kwast T; Toi A; Finelli A; Kulkarni G; Hamilton R; Zlotta AR; Trachtenberg J; Ghai S; Fleshner NE
J Urol; 2017 Jan; 197(1):75-83. PubMed ID: 27457260
[TBL] [Abstract][Full Text] [Related]
10. Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group.
Patel HD; Tosoian JJ; Carter HB; Epstein JI
JAMA Oncol; 2018 Jan; 4(1):89-92. PubMed ID: 28715578
[TBL] [Abstract][Full Text] [Related]
11. Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-Risk" Prostate Cancer: Implications for Active Surveillance.
Morlacco A; Cheville JC; Rangel LJ; Gearman DJ; Karnes RJ
Eur Urol; 2017 Sep; 72(3):442-447. PubMed ID: 27574819
[TBL] [Abstract][Full Text] [Related]
12. Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions.
Hoffman RM
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):197-201. PubMed ID: 23271773
[TBL] [Abstract][Full Text] [Related]
13. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.
van Tol-Geerdink JJ; Willem Leer J; Weijerman PC; van Oort IM; Vergunst H; van Lin EN; Alfred Witjes J; Stalmeier PF
BJU Int; 2013 Apr; 111(4):564-73. PubMed ID: 22882966
[TBL] [Abstract][Full Text] [Related]
14. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.
Scherr KA; Fagerlin A; Hofer T; Scherer LD; Holmes-Rovner M; Williamson LD; Kahn VC; Montgomery JS; Greene KL; Zhang B; Ubel PA
Med Decis Making; 2017 Jan; 37(1):56-69. PubMed ID: 27510740
[TBL] [Abstract][Full Text] [Related]
15. Evolution and Predictors of Patient-Caregiver Concordance on States of Life-Sustaining Treatment Preferences over Terminally Ill Cancer Patients' Last Six Months of Life.
Wen FH; Chou WC; Chen JS; Chang WC; Hsieh CH; Tang ST
J Palliat Med; 2019 Jan; 22(1):25-33. PubMed ID: 30234418
[TBL] [Abstract][Full Text] [Related]
16. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery.
Tosoian JJ; Sundi D; Trock BJ; Landis P; Epstein JI; Schaeffer EM; Carter HB; Mamawala M
Eur Urol; 2016 Apr; 69(4):576-581. PubMed ID: 26456680
[TBL] [Abstract][Full Text] [Related]
17. Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance.
Colicchia M; Morlacco A; Rangel LJ; Carlson RE; Dal Moro F; Karnes RJ
Eur Urol Focus; 2019 May; 5(3):425-432. PubMed ID: 29306730
[TBL] [Abstract][Full Text] [Related]
18. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
[TBL] [Abstract][Full Text] [Related]
19. Population-Based Assessment of Determining Treatments for Prostate Cancer.
Chamie K; Williams SB; Hu JC
JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
[TBL] [Abstract][Full Text] [Related]
20. Association of Decision-making with Patients' Perceptions of Care and Knowledge during Longitudinal Pulmonary Nodule Surveillance.
Sullivan DR; Golden SE; Ganzini L; Wiener RS; Eden KB; Slatore CG
Ann Am Thorac Soc; 2017 Nov; 14(11):1690-1696. PubMed ID: 28489453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
